296 related articles for article (PubMed ID: 31279295)
21. [Angiotensin II receptor blockers: current status and future prospects].
Corvol P; Plouin PF
Drugs; 2002; 62 Spec No 1():53-64. PubMed ID: 12036389
[TBL] [Abstract][Full Text] [Related]
22. The renin-angiotensin-aldosterone system and its therapeutic targets.
Mirabito Colafella KM; Bovée DM; Danser AHJ
Exp Eye Res; 2019 Sep; 186():107680. PubMed ID: 31129252
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin-(1-7): A Novel Peptide to Treat Hypertension and Nephropathy in Diabetes?
Padda RS; Shi Y; Lo CS; Zhang SL; Chan JS
J Diabetes Metab; 2015 Oct; 6(10):. PubMed ID: 26793405
[TBL] [Abstract][Full Text] [Related]
24. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
[TBL] [Abstract][Full Text] [Related]
25. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
Simões E Silva AC; Teixeira MM
Pharmacol Res; 2016 May; 107():154-162. PubMed ID: 26995300
[TBL] [Abstract][Full Text] [Related]
26. Autophagy protects against senescence and apoptosis via the RAS-mitochondria in high-glucose-induced endothelial cells.
Chen F; Chen B; Xiao FQ; Wu YT; Wang RH; Sun ZW; Fu GS; Mou Y; Tao W; Hu XS; Hu SJ
Cell Physiol Biochem; 2014; 33(4):1058-74. PubMed ID: 24732710
[TBL] [Abstract][Full Text] [Related]
27. Renin-angiotensin system blocking drugs.
Robles NR; Cerezo I; Hernandez-Gallego R
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
[TBL] [Abstract][Full Text] [Related]
28. Renin Angiotensin System and Cytokines in Chronic Kidney Disease: Clinical and Experimental Evidence.
Saldanha da Silva AA; Rodrigues Prestes TR; Lauar AO; Finotti BB; Simoes E Silva AC
Protein Pept Lett; 2017 Nov; 24(9):799-808. PubMed ID: 28820061
[TBL] [Abstract][Full Text] [Related]
29. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme 2 in lung diseases.
Kuba K; Imai Y; Penninger JM
Curr Opin Pharmacol; 2006 Jun; 6(3):271-6. PubMed ID: 16581295
[TBL] [Abstract][Full Text] [Related]
31. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
32. Local ocular renin-angiotensin-aldosterone system: any connection with intraocular pressure? A comprehensive review.
Holappa M; Vapaatalo H; Vaajanen A
Ann Med; 2020 Aug; 52(5):191-206. PubMed ID: 32308046
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin-(1-7): beyond the cardio-renal actions.
Passos-Silva DG; Verano-Braga T; Santos RA
Clin Sci (Lond); 2013 Apr; 124(7):443-56. PubMed ID: 23249272
[TBL] [Abstract][Full Text] [Related]
34. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
[TBL] [Abstract][Full Text] [Related]
35. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives.
Ribeiro VT; de Souza LC; Simões E Silva AC
Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744
[TBL] [Abstract][Full Text] [Related]
36. Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition.
Sullivan JC
Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1220-6. PubMed ID: 18287217
[TBL] [Abstract][Full Text] [Related]
37. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
Mori J; Zhang L; Oudit GY; Lopaschuk GD
J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
[TBL] [Abstract][Full Text] [Related]
38. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes.
Major TC; Olszewski B; Rosebury W; Okerberg C; Carlson T; Ostroski R; Schroeder R; Kowala MC; Leadley R
Cardiovasc Drugs Ther; 2008 Dec; 22(6):469-78. PubMed ID: 18679781
[TBL] [Abstract][Full Text] [Related]
39. Renin-angiotensin system blockade at the level of the angiotensin converting enzyme or the angiotensin type-1 receptor: similarities and differences.
Stergiou GS; Skeva II
Curr Top Med Chem; 2004; 4(4):473-81. PubMed ID: 14965313
[TBL] [Abstract][Full Text] [Related]
40. Local renin-angiotensin system molecular mechanisms in intrauterine adhesions formation following gynecological operations, new strategy for novel treatment.
Shabanian S; Khazaie M; Ferns GA; Arjmand MH
J Obstet Gynaecol; 2022 Aug; 42(6):1613-1618. PubMed ID: 35260037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]